Overview

Single Dose Escalation First Time in Human PK Study

Status:
Completed
Trial end date:
2009-12-07
Target enrollment:
Participant gender:
Summary
This is a first time in human (FTIH) study of single escalating doses of investigational study drug to investigate safety, tolerability, and pharmacokinetics in healthy subjects
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline